Chemistry:FT-104
From HandWiki
Short description: Chemical compound
 | |
| Identifiers | |
|---|---|
| |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C21H30N2O |
| Molar mass | 326.484 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
FT-104 (4-glutaryloxy-N,N-diisopropyltryptamine) is a psychedelic tryptamine derivative which is a prodrug ester of the well known designer drug 4-HO-DiPT. It is one of a number of related derivatives developed for potential medical applications, and is in human clinical trials as a possible treatment for postpartum depression and treatment-resistant depression.[1][2][3][4]
See also
- 4-AcO-DiPT
- 4-PrO-DMT
- THC hemisuccinate
References
- ↑ "An Inside Look into Field Trip's Next-Generation Psychedelic, FT-104". 11 August 2022. https://psychedelicspotlight.com/an-inside-look-into-field-trips-next-generation-psychedelic-ft-104/.
- ↑ Bryson N. Tryptamine Prodrugs. Patent WO 2022/000091
- ↑ Slassi A, Araujo J. Psilocin derivatives as serotonergic psychedelic agents for the treatment of cns disorders. Patent application US 2022/0024956
- ↑ Slassi A, et al. Hallucinogen-Fatty Acid Combination. Patent WO 2022/246572
 |  |
